Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature Review.
Medicina (Kaunas). 2023 Apr 1;59(4):696. doi: 10.3390/medicina59040696.
Medicina (Kaunas). 2023.
PMID: 37109654
Free PMC article.
Review.
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature.
Stanciu IM, Parosanu AI, Orlov-Slavu C, Iaciu IC, Popa AM, Olaru CM, Pirlog CF, Vrabie RC, Nitipir C.
Stanciu IM, et al. Among authors: vrabie rc.
Diagnostics (Basel). 2023 Mar 5;13(5):987. doi: 10.3390/diagnostics13050987.
Diagnostics (Basel). 2023.
PMID: 36900131
Free PMC article.
Review.
Item in Clipboard
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma.
Parosanu AI, Pirlog CF, Slavu CO, Stanciu IM, Cotan HT, Vrabie RC, Popa AM, Olaru M, Iaciu C, Bratu LI, Baicoianu IF, Moldoveanu O, Baston C, Nițipir C.
Parosanu AI, et al. Among authors: vrabie rc.
Curr Oncol. 2023 Feb 17;30(2):2457-2464. doi: 10.3390/curroncol30020187.
Curr Oncol. 2023.
PMID: 36826148
Free PMC article.
Item in Clipboard
Cite
Cite